文献速递肝病消化道出血

基于慢性肝衰竭联盟急性失代偿评分对Child-Pugh B级肝硬化合并急性食管胃静脉曲张出血患者进行风险分层

Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding.
PubMed 文献 · Hepatology · 2021-01-23

本研究汇总中国2010至2017年两项研究中608例接受标准治疗的Child-Pugh B级肝硬化合并急性食管胃静脉曲张出血患者个体数据,评估慢性肝衰竭联盟急性失代偿评分(CLIF-C ADs)的风险分层价值。CLIF-C ADs对6周和1年死亡的预测能力优于内镜下活动性出血等模型,据此分为低、中、高危三组,6周死亡风险分别为5.6%、16.8%和25.4%。CLIF-C ADs预测6周死亡或再出血复合终点不够理想(AUC 0.588),联合白蛋白、血小板、活动性出血和腹水的列线图将AUC提升至0.725。

要点

  • CLIF-C ADs可将Child-Pugh B级肝硬化合并急性静脉曲张出血患者分为低危(<48)、中危(48-56)、高危(>56)三层。
  • 三组6周死亡风险分别为5.6%、16.8%和25.4%。
  • CLIF-C ADs预测6周死亡或再出血复合终点AUC为0.588,列线图提升至0.725。

核心结论

  • 在Child-Pugh B级肝硬化合并急性食管胃静脉曲张出血患者中,使用CLIF-C ADs进行风险分层可识别死亡高风险亚组,该亚组可能从早期TIPS获得生存获益。
  • 数据驱动的列线图改善了6周死亡或再出血的预测准确性,可能有助于在随机试验中对患者进行分层。
  • 需要在不同病因患者中对这些发现进行进一步外部验证。

研究设计与样本

  • 汇总分析中国2010年至2017年间两项研究中608例接受标准治疗的Child-Pugh B级肝硬化合并急性食管胃静脉曲张出血患者的个体数据。

主要发现

  • CLIF-C ADs对6周和1年死亡的C指数分别为0.715和0.708,显著优于内镜下活动性出血(6周0.633,P<0.001;1年0.556,P<0.001)及其他预后模型。
  • 经X-tile软件确定最佳截断值,将患者分为低危(CLIF-C ADs<48)、中危(CLIF-C ADs 48-56)和高危(CLIF-C ADs>56),6周死亡风险分别为5.6%、16.8%和25.4%。
  • CLIF-C ADs预测6周死亡或再出血复合终点的AUC为0.588,表现不令人满意。
  • 纳入CLIF-C ADs组分及白蛋白、血小板、活动性出血和腹水的列线图显著提高预测准确性(AUC 0.725)。

关键数值与推荐

  • CLIF-C ADs低危组为<48,中危组为48-56,高危组为>56。
  • 低危、中危、高危组6周死亡风险分别为5.6%、16.8%、25.4%。
  • CLIF-C ADs预测6周死亡或再出血复合终点的AUC为0.588。
  • 列线图预测6周死亡或再出血的AUC为0.725。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要在不同病因患者中对这些发现进行进一步外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Optimal candidates for early transjugular intrahepatic portosystemic shunt (TIPS) in patients with Child-Pugh B cirrhosis and acute variceal bleeding (AVB) remain unclear. This study aimed to test the hypothesis that risk stratification using the Chronic Liver Failure Consortium Acute Decompensation score (CLIF-C ADs) may be useful to identify a subgroup at high risk of mortality or further bleeding that may benefit from early TIPS in patients with Child-Pugh B cirrhosis and AVB. APPROACH AND RESULTS: We analyzed the pooled individual data from two previous studies of 608 patients with Child-Pugh B cirrhosis and AVB who received standard treatment between 2010 and 2017 in China. The concordance index values of CLIF-C ADs for 6-week and 1-year mortality (0.715 and 0.708) were significantly better than those of active bleeding at endoscopy (0.633 [P < 0.001] and 0.556 [P < 0.001]) and other prognostic models. With X-tile software identifying an optimal cutoff value, patients were categorized as low risk (CLIF-C ADs <48), intermediate risk (CLIF-C ADs 48-56), and high risk (CLIF-C ADs >56), with a 5.6%, 16.8%, and 25.4% risk of 6-week death, respectively. Nevertheless, the performance of CLIF-C ADs for predicting a composite endpoint of 6-week death or further bleeding was not satisfactory (area under the receiver operating characteristics curve [AUC], 0.588). A nomogram incorporating components of CLIF-C ADs and albumin, platelet, active bleeding, and ascites significantly improved the prediction accuracy (AUC, 0.725). CONCLUSIONS: In patients with Child-Pugh B cirrhosis and AVB, risk stratification using CLIF-C ADs identifies a subgroup with high risk of death that may derive survival benefit from early TIPS. With improved prediction accuracy for 6-week death or further bleeding, the data-driven nomogram may help to stratify patients in randomized trials. Future external validation of these findings in patients with different etiologies is required.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lv Y, Wang Z, Li K, et al. Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding. Hepatology. 2021. PMID: 32706906. doi:10.1002/hep.31478

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。